TERMS & CONDITIONS NEWS SITEMAP ABOUT MEDICADEMY CONTACT TEACHERS
Medicademy - welcome page Lif Uddannelse
Medicademy Module R8: Clinical Development and Documentation
Registration deadline:
18 April 2012
Exam:
Date of examination: June 1, 2012
 
You can take the examination in your own country!
 
Medicademy arranges examinations at Embassies, Universities etc. all over the world.
 
Information about examination form etc. will follow.
 
Remember to register for the exam separately!
Register here!
 
Registration is closed
Startdate:
24 April 2012 - 27 April 2012
Purpose:
This module provides the students with an excellent opportunity to gain an overview of the regulatory aspects of global clinical development processes and the documentation needed for the clinical sections of CTD (Modules 2 and 5). Clinical sections are especially important, when completing a marketing authorisation of a new product or product labelling and in meeting the needs of patients and the marketing of the product.

The module is targeted at regulatory employees, who wish to gain a better understanding of the interrelationships and complexities in clinical development and the current regulatory requirements for developing a new treatment. Further, it provides clinical development staff with the opportunity to gain a better understanding of the relation between regulatory and clinical strategies and of the documents that must be prepared prior to regulatory approval.

By the end of this module, the student should be able to:
- understand the regulatory requirements for obtaining a global marketing authorisation for a new treatment, including pharmacological testing, exploratory and confirmatory investigations, and commitments to be completed post-marketing

- create, analyse and evaluate a regulatory strategy plan for the clinical development of a new drug

- familiarise with the principles of clinical development from phase I to IV

- learn how to create competitive product information by optimising the clinical development plan and supporting the desired labelling 
Content:
The program concentrates on the clinical development process and with a focus on EU primarily.

Questions to be answered during the Module: 
 
  • How do we know that we are doing the right studies to satisfactorily demonstrate the efficacy and safety of the new treatment?
  • Will we get product labelling that meets marketing’s needs?
  • Do we have enough patients in our development program?
  • Can we speed up the development process and the regulatory review?
  • Can the drug development plans support global marketing also through life cycle management?
  • How is clinical risk assessment handled during development and the pharmacovigilance process?
     
Subjects:
• Global Regulatory Requirements and New Trends
• General Considerations for Clinical Trials
• Global Development Plan
• Target Product Profile – Global Focus
• Clinical Protocol
• Clinical Efficacy, Safety and Benefit-Risk
• Endpoints: Treatment Monitoring
• Clinical Study
• Integrated Clinical Study Report (ICH E3)
• Pharmacokinetic and Pharmacodynamics
• Special Populations
• Interactions and Drug/Drug Interactions
• Early Clinical Development
• Drug Safety – from Non-clinical to Post-approval Activities
• Statistics in Clinical Trials
• Studies in Paediatric Population
• Clinical Summaries and Clinical Overview
• Risk Management in a Pharmaceutical Company
• Interactions with Health Authorities
• Pharmacovigilance/Post-Marketing Risk Assessment
• Post-approval Studies 
 
The various subjects will be presented by lecturers with extensive experience and expertise within drug development and regulatory affairs from the industry as well as the health agencies. Workshops are an important part of the programme and provide students with the opportunity to interact with lecturers as well as with each other.
 
Course Leaders:
• Vibeke Bjerregaard, MSc Pharm, Regulatory Product Manager, Novo Nordisk A/S, Denmark
• Ann Christine Korsgaard, MSc Pharm, Vice President, Regulatory Affairs, Genmab A/S, Denmark
 
Lecturers:
• Sheelagh Corcoran
, Training Consultant, UK
• Anders Dejgaard, Corporate Vice President, Chief Medical Officer for Modern Insulin, Denmark
• Linda Donnini, PAREXEL, Medical Writing Services, PAREXEL, UK
• Steffen Thirstrup, Chief Medical Officer, Head of Department, Danish Medicines Agency, Denmark
• Steven B. Johnson, Vice President, Regulatory Affairs, Novo Nordisk A/S, USA
• Thanos Konstantakopoulos, PhD, Senior Regulatory Associate - European Regulatory Affairs, Lilly, United Kingdom
• Ida Holme Håkonsson, Head of Section, MD, PV Science, LEO Pharma A/S, Denmark
• Sinan Bardakci Sarac, Assessor, Consumer Safety Division, Danish Medicines Agency, Denmark
• Vibeke Bjerregaard, Regulatory Product Manager, Novo Nordisk A/S, Denmark
• Dr. Birka Lehmann, Director and Professor, BfArM - Federal Institute for Drugs and Medical Devices, Germany
• Martin Schultz, International Clinical Trial Leader, Genmab A/S, Denmark
 Mark Ainsworth, Vice Chairman, Board of Registration, The Danish Medicines Agency and Consultant Gastroenterologist, Department of Gastroenterology, Copenhagen University Hospital at Herlev, Denmark
• Birgitte Søgaard, Head of Department, Clinical Pharmacology, H. Lundbeck A/S, Denmark
• Janet Wade, Senior Consultant, Exprimo, Sweden
• Nedjad Losic, Associate Director Statistics, Genmab A/S, Denmark
• Dr Malcolm Barratt-Johnson, Managing Partner, The BJ Partnership LLP, UK
• Torben Balchen, Director, DanTrials ApS, Denmark
• Marie Aavang Geist, Risk Management Specialist Pharmacovigilance, H. Lundbeck A/S, Denmark
 
Prerequisites:
In order to secure the professional level of the education. The participants must have a educational background at bachelor level within a relevant area and at least two years’ experience within Regulatory Affairs or equivalent qualifications. Please note that applications will be considered in order of receipt.
Medicademy accept up to 10 - 20 % of the seats at a module to be occupied by applicants who have none or limited experience within the regulatory affairs area. These participants must have experience within the pharmaceutical/biological area that qualify them to benefit from the training and to participate actively during the module. The participation will be considered on a case-by-case basis.
 
Literature:
A list of recommended literature will be send to the participants approx. 4 weeks prior to the start of the module.
The list will be divided into mandatory and optional reading. The mandatory references is part of the examination syllabus.
The participants are expected to study and be familiar with the mandatory references in advance of the module.

Accomodation:
Hotel Twentyseven
Hotel Twentyseven is located in the heart of Copenhagen, close to the Town Hall Square, the Tivoli Gardens, and Copenhagen Central Station, and airport trains, S-trains, regional trains, and busses leave from the sta­tion regularly. Hotel Twentyseven has a special atmosphere based on unique experiences, living design, seductive comfort, hospitality, and an uncomplicated life. All the 200 rooms in the hotel have been designed in the well-known Scandinavian design tradition by leading Danish designers & architects. www.hotel27.dk
Fixed prices – breakfast included: Small single room - DKK 930 (approx. EUR 125), Double room for 1 person – DKK 1,080 (approx. EUR 145)

Shuttle Bus - Included in the Course Fee!
Medicademy arrange transportation by bus every day from Hotel Twentyseven in the morning to Medicademy and back again in the evening from Medicademy to Hotel Twentyseven – included in the course fee!
 
Networking Dinner - Included in the Course Fee!
The networking dinner takes place at Hotel Twentyseven on the first night of the module - April 24 , 2012!
 
Plads til diskussion – rigtig godt​
Ann-Lisbeth Aarup Nielsen - ALK-Albelló - Regulatory Affairs Officer

Tina Jensen

Tina Jensen is Program Director, Medicademy Regulatory Affairs and responsible for Introduction to Drug Registration.
 
Phone: +45 39 15 09 14
Lif Education, Diploma in Basic Pharmaceutical Medicine, Clinical Research, Drug Development, Medicademy Pharmacovigilance, Medicademy Regulatory Affairs, RA, PV, Pharmacovigilance, Regulatory Affairs
Regulatory Affairs
Course overview
About R.A.
Requirements
MPRA
Diploma
Individual Modules
Steering Committee
Faculty
Pharmacovigilance
About Pharmacovigilance
Course Overview
Entry Requirements
Diploma
Individual Modules
Steering Committee
Faculty
About
About Medicademy
About Lif
Course Structure
Examination
Course Facilities, Accomodation, Transportation and Networkding Dinner
Contact
Lersø Parkallé 101    DK-2100 Copenhagen    Phone: +45 39 15 09 10    Fax. +45 39 27 60 70    mail@medicademy.net